Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Shulman

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Journal of Clinical Microbiology|March 4, 2000
Resolution of the pathways of poliovirus type 1 transmission during an outbreakL M Shulman, R Handsher, C F Yang, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 1, 2014
Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013L M Shulman, E Gavrilin, J Jorba, et al.
Virology|September 1, 1984
Antibodies to chromosome 21 coded cell surface components block binding of human alpha interferon but not gamma interferon to human cellsL M Shulman, M E Kamarck, D L Slate, et al.
Parkinsonism & Related Disorders|March 15, 2001
The long-term safety and efficacy of pramipexole in advanced Parkinson's diseaseW J. Weiner, S A. Factor, J Jankovic, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 3, 2013
Insidious reintroduction of wild poliovirus into Israel, 2013E Anis, E Kopel, S R Singer, et al.
Journal of Clinical Microbiology|October 4, 2000
Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in IsraelL M Shulman, Y Manor, R Handsher, et al.
Vaccine|February 5, 2008
Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in IsraelT A Swartz, M S Green, R Handscher, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Journal of Clinical Microbiology|March 4, 2000
Resolution of the pathways of poliovirus type 1 transmission during an outbreakL M Shulman, R Handsher, C F Yang, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 1, 2014
Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013L M Shulman, E Gavrilin, J Jorba, et al.
Virology|September 1, 1984
Antibodies to chromosome 21 coded cell surface components block binding of human alpha interferon but not gamma interferon to human cellsL M Shulman, M E Kamarck, D L Slate, et al.
Parkinsonism & Related Disorders|March 15, 2001
The long-term safety and efficacy of pramipexole in advanced Parkinson's diseaseW J. Weiner, S A. Factor, J Jankovic, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 3, 2013
Insidious reintroduction of wild poliovirus into Israel, 2013E Anis, E Kopel, S R Singer, et al.
Journal of Clinical Microbiology|October 4, 2000
Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in IsraelL M Shulman, Y Manor, R Handsher, et al.
Vaccine|February 5, 2008
Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in IsraelT A Swartz, M S Green, R Handscher, et al.
Pageof 8